China Shineway Pharmaceutical Group Limited - About Shineway

HKEx Stock Code: 02877

		Company Profile

		Chairman's Statement

		Corporate Structure

		Awards and Achievements

		Management Team

		Corporate Information

China Shineway obtained Australian GMP Certificate issued by the Therapeutic Goods Administration of Australian for its manufacturing facilities of soft capsules, granules and five other dose forms

China Shineway received the China Outstanding Corporate Culture Award in the 5^th China Corporate Culture Conference

China Shineway was elected as one of the National Outstanding Employment Relation Enterprises

In the 3rd China International Patents and Famous Brand Conference held by the Department of Intellectual Properties, China Shineway received Gold Awards for its three patents on medicine formulae and compounds

China Shineway was recognized as one of the year 2005 Top Ten Most Profitable Enterprises of Chinese Medicine Manufacturing Industry

Li Zhenjiang, Chairman of the Board, was awarded as "Senior outstanding Chinese medicine entrepreneur who brings honor to the prominent national culture".

Li Zhenjiang, Chairman of the Board, was named as one of the "2006 Top 10 Most Innovative Persons of the Pharmaceutical Industry of China".

China Shineway was honored as one of "China 500 Most Valuable Brand".

China Shineway received approval by the Ministry of Personnel of the PRC to establish post doctoral research station.

China Shineway was list among the "2005 Top 100 Companies in China's Pharmaceutical Industry"

China Shineway Obtained an "AAA Certificate of Conformity for Measurement Management Systems" issued by CMS - a certification unit under the General Administration of Quality Supervision, Inspection and Quarantine of the PRC. China Shineway is the first Chinese medicine manufacturer to receive such certificate.

China Shineway was recognized as one of the most admirable pharmaceutical companies in China by the World Manager Magazine.

Wufu Xin Nao Qing Soft Capsule was named "the Most Influential Brand in 2005 / Top 100 Company in Chinese Pharmaceutical Industry"

Li Zhenjiang, Chairman of the Board, was named as one of the "2005 Top 10 Most Innovative Persons of the Pharmaceutical Industry of China" by Medicine Economic Press.